Cuellar-González JV, Correa-Rotter R

Idioma: Español
Referencias bibliográficas: 39
Paginas: 187-194
Archivo PDF: 67.16 Kb.

FRAGMENTO

Para muchos pacientes con insuficiencia renal crónica avanzada, el trasplante renal es el tratamiento de elección. Esta opción debe ser considerada tempranamente ya que en algunos pacientes el trasplante puede realizarse antes de que se requiera diálisis para sustituir la función renal, es decir, en forma anticipada.
El proceso de evaluación del potencial receptor de un trasplante renal debe hacerse en forma multidisciplinaria por un equipo de trasplante el cual incluye: nefrólogo, cirujano de trasplantes, urólogo, trabajadora social, enfermeras y expertos en tipificación tisular. En muchos centros el receptor y el donador son evaluados por diferentes equipos de médicos, para prevenir la influencia del médico del receptor sobre la evaluación de los probables donadores.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Kasiske BL. Prospective renal transplant recipients and living donors. Surg Clin North Am 1998; 78(1): 27-39.

2. Cofre R, López-Gómez J, Moreno F, et al. Changes in quality of life after renal transplantation. Am J Kidney Dis 1998; 32: 93-100.

3. Wolfe RA, Ashiby VB, Midford EL, et al. Comparison of mortality in all patients on dialysis, patients and dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725-30.

4. Kasiske BL, Cangro CB, Hariharan S, et al. The evaluation of renal transplant candidates: clinical practical guidelines. Am J Transplantation 2001; 1(Suppl. 2): 7-95.

5. Hoitsma A, Hillbrands L. Evaluation of renal transplant donor and recipient. In: Johnson RJ, Feehally J (eds.). Comprehensive Clinical Nephrology. 2nd Ed. Spain: Mosby; 2004, p. 1071-82.

6. Fritsche L, Vanrenterghem Y, Nordal KP, et al. Practice variations on the evaluation of adult candidates for cadaveric kidney transplantation: a survey of the European Transplant Centers. Transplantation 2000; 15(Suppl. 7): 1-85.

7. Berthoux F, Abramowicz D, Bradley B, et al. European best practice guidelines for renal transplantation (part 1). Nephrol Dial Transplant 2000: 15(Suppl. 7): 1-85.

8. U.S. Renal Data System. Causes of deaths. USRDS 1999 Annual Data Report. Bethesda, Md. National Institutes of Health, National Institute of Diabetes, Dig Kidney Dis; 1999. p 89-100.

9. Kendrickk E. Evaluación del receptor del trasplante. En: Danovitch GM (ed). Trasplante renal. 3a. Ed. Madrid, España: Marbán; 2002, p. 138-45.

10. Kasiske BL, Ramos EL, Gaston RS, et al. The evaluation of renal transplant candidates: clinical practical guidelines. J Am Soc Nephrol 1995; 51: 351-88.

11. Power RE, O’Malley MS, Khan MS, Murphy DM, Hickey DP. Renal transplantation in patients with an augmentation cystoplasty. BJU International 2000; 86: 26-31.

12. Glazier DB, Whang MI, Geffner SR, et al: Evaluation of voiding cystourethrography prior to renal transplantation. Transpl 1996; 62: 1762-5.

13. Sullivan ME, Reynard JM, Cranston DW. Renal transplantation into the abnormal lower urinary tract. BJU International 2003; 92: 510-15.

14. Bain VG. Hepatitis B in transplantation. Transpl Infect Dis 2000; 2: 153-65.

15. Chan TM, Lok ASF, Cheng IKT, Chan RT: Prevalence of hepatitis C virus infection in hemodialysis patients: a longitudinal study comparing the results of RNA and antibody assays. Hepatology 1993; 17: 5-8.

16. Pereira BJG. Hepatitis C in organ transplantation. Its significance and influence on transplantation policies. Curr Op Nephrol Hypertens 1993; 2: 912-22.

17. Morales J, Campistol J. Transplantation in patients with Hepatitis C. J Am Soc Nephrol 2000; 11: 1343-53.

18. Stock PG, Roland ME, Carlson L, Fraise CE, et al: Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study. Transpl 2003; 76: 370-5.

19. Abbott K, Swanson J, Agodoa L, Kimmel P. Human immunodeficiency virus infection and kidney transplantation in the era of highly active antiretroviral and modern immunosuppresion. J Am Soc Nephrol 2004; 15: 1633-9.

20. Brennan D. Cytomegalovirus. In: Renal transplant. J Am Soc Neprhol 2001; 12: 848-55.

21. Aranda V, Alberú J, Soto-Ramírez LE, González-Aguirre H, Muñoz T, Mancilla E, Diliz H, Correa-Rotter R. Efectividad de la terapia anticipada con ganciclovir en receptores de trasplante renal de alto riesgo (R-/D+) para desarrollo de enfermedad por citomegalovirus. Rev Invest Clin 2002; 54: 198-203.

22. John GT, Shankar V. Mtcobacterial infectons in organ transplant recipients. Semin Respir Infect 2002; 16: 257-61.

23. Greenstein A, Siegal B. Compliance and non compliance in patients with a functioning renal transplant: a multicenter study. Transpl 1998; 66: 1718-22.

24. Benedetti E, Asolati M, Duna T, et al. Kidney transplantation in recipients with mental retardation. Am J Kidney Dis 1998; 31: 509-16.

25. Le A, Wilson R, Douwk K, et al. Prospective risk stratification in renal transplant candidates for cardiac death. Am J Kidney Dis 1994; 24: 65-71.

26. Lin K, Steward D, Cooper S, Davis CL. Pretransplant cardiac testing for kidney-pancreas transplant candidates and association with cardiac outcomes. Clin Transplant 2001; 15: 260-73.

27. Mansle CL, Wang Y, Rector T, et al. Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure. Lancet 1992; 340: 998-1002.

28. Reddy VA, Chen AC, Johnson HK, et al. Cardiac surgery alter renal transplantation. Am Surg 2002; 68: 154-8.

29. Tesi RJ, Elkhammas EA, Davies EA, et al. Renal transplantation in older people. Lancet 1994; 343: 461-4.

30. Bradley BA. Rejection and recipient age. Transpl Immunol 2002; 10: 125-32.

31. Manske CL, Wilson RF, Wang Y. Atheroesclerosis vascular complications in diabetic transplant patients. Am J Kidney Dis 1997; 29: 601-7.

32. National Kidney Foundation: K/DOQI. Clinical practices guidelines for chronic renal disease: evaluation, classification and stratification. Am J Kidney Dis 2002; 39(Suppl. 2): S1-S246.

33. Ashley EA, Raxwal V, Finlay M, Froelicher V. Diagnosis coronary artery diseases in diabetic patients. Diabetes Metab Res Rev 2002; 18: 201-8.

34. Gaston R, Bessadonna G, Cosio F, et al. Transplantation in the diabetic patient with advanced chronic renal disease: a task force report. Am J Kidney Dis 2004; 44 (3): 529-42.

35. Meier-Kriesche HU, Arndorfer JA, Kaplan B. The impact of body mass index or renal transplant outcomes: a significant independent risk factor for graft failure and patients death. Transpl 2002; 73: 70-4.

36. Yamamoto M, Hanley E, Hahn AB, et al. The impact of obesity in renal transplantation: an analysis of paired of cadavers kidney. Clin Transpl 2002; 16: 252-6.

37. Bennett WM, McEvoy KM, Henell KR, Valente JF, Douzdijan I. Morbid obesity not preclude successful renal transplantation. Clin Transpl 2004; 18: 85-93.

38. Ward MM. Outcomes of renal transplantation among patients with end stage renal disease caused by lupus nephritis. Kidney Int 2000; 57: 2136-43.

39. Hariharan S Adams MB, Brennan DC, et al. Recurrent and de novo glomerular disease alter renal transplantation: a report from renal allograft disease registry. Transplant Proc 1999; 31: 223-30.